【ChiCTR-IOR-17013259】Breaking up Prolonged Sitting with Light-intensity Walking and Sitting Bouts Duration on Postprandial Metabolic Responses in Overweight/Obese Male Adults
ChiCTR-IOR-17013259
正在进行
/
/
/
2017-11-03
/
/
Overweight/Obesity
Breaking up Prolonged Sitting with Light-intensity Walking and Sitting Bouts Duration on Postprandial Metabolic Responses in Overweight/Obese Male Adults
Breaking up Prolonged Sitting with Light-intensity Walking and Sitting Bouts Duration on Postprandial Metabolic Responses in Overweight/Obese Male Adults
Breaking up Prolonged Sitting with Light-intensity Walking and Sitting Bouts Duration on Postprandial Metabolic Responses in Overweight/Obese Male Adults
随机交叉对照
其它
Randomized
Single-blind for Trial subjects
No
/
25
/
1990-01-01
1990-01-01
/
1. Chinese men aged between 18 and 34 years; 2. With overweight/obesity (Body Mass Index is higher than 22.9 km/m^2); 3. Physically inactive (moderate-intensity physical activity is less than 150 minutes per week for the past 3 months); 4. Total time spent sitting is more than 5 hours per day; 5. Fluent in English.；
请登录查看1. Allergic to milk or gluten; 2. With history of cardiovascular disease and/or diabetes; 3. Fasting blood glucose is over than 7 mmol/L, and/or 2-hour postprandial glucose in the 75-g Oral glucose tolerance test is over than 199 mg/dL, and/or HbA1C is over than 6.4%; 4. Smoker; 5. With conditions that alter limit capability to walk on a treadmill; 6. Taking any medications known to affect lipid or glucose metabolism; 7. Not fluent in English.；
请登录查看香港中文大學教育學院
/
香港中文大學教育學院的其他临床试验
Department of Sports Science and Physical Education, Faculty of Education, The Chinese University of Hong Kong的其他临床试验
最新临床资讯
-
Nat Rev Clin Oncol｜AI赋能肿瘤临床试验：从流程优化到证据生成的全景透视
智药邦2026-08-12
-
康臣药业1类新药糖肾方“芪箭颗粒”获NMPA临床研究许可
康臣药业2026-08-12
-
璎黎药业2026-08-12
-
幂方健康基金2026-08-12
-
细胞与基因治疗领域2026-08-12
-
云南白药2026-08-12
-
细胞治疗前沿2026-08-12
-
广州达博生物制品有限公司2026-08-12
-
医药笔记2026-08-12
-
医药笔记2026-08-12
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-08-13
-
2026-08-13
-
2026-08-13
-
摩熵咨询 20 8
-
摩熵咨询 34 27
-
摩熵咨询 20 5
-
颁布机构：四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构：国家医保局 2026-07-31
-
颁布机构：国家药品审评中心（CDE） 2026-07-24
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-08-13
-
2026-08-13
-
2026-08-13
-
摩熵咨询 35 36
-
摩熵咨询 28 38
-
摩熵咨询 34 18
-
颁布机构：国家市场监督管理总局 2026-08-10
-
颁布机构：国家市场监督管理总局 2026-05-29
-
颁布机构：国家市场监督管理总局 2026-05-29